Ombretta Melaiu

6PUBLICATIONS
19CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Neural networks
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 26, 2026
Single-cell profiling reveals a novel CAF subpopulation linking stromal heterogeneity to immune suppression in breast cancer subtypes.

|Mar 28, 2026
Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer.

Simone Ielpo, Francesca Barberini, Alice Gaiba

|Feb 13, 2026
Fibronectin Is a Likely Therapeutic Target Shared by Oral and Breast Carcinomas.

Silvia Pomella, Roberto Bei, Ombretta Melaiu

|Aug 14, 2025
The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral Keratinocytes.

Silvia Pomella, Lucrezia D'Archivio, Matteo Cassandri

|Jan 26, 2024
Clinical Feature Ranking Based on Ensemble Machine Learning Reveals Top Survival Factors for Glioblastoma Multiforme.

Gabriel Cerono, Ombretta Melaiu, Davide Chicco

|Aug 27, 2021
Quantification of the Immune Content in Neuroblastoma: Deep Learning and Topological Data Analysis in Digital Pathology.

Nicole Bussola, Bruno Papa, Ombretta Melaiu

Pageof 1

Frequent Collaborators

2 joint publications

Silvia Pomella

2 joint publications

Giovanni Barillari

1 joint publications

Nicole Bussola

1 joint publications

Bruno Papa